Dr. Halperin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Unit 426
Houston, TX 77030Phone+1 713-792-2330- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2012- Brigham and Women's HospitalInternship, Internal Medicine, 2009 - 2010
Weill Cornell MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2014 - 2026
OK State Medical License 2020 - 2025
AZ State Medical License 2023 - 2025
WA State Medical License 2023 - 2025
TN State Medical License 2023 - 2024
GA State Medical License 2023 - 2024- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Career Development Award American Society of Clinical Oncology, 2018
- Waun Ki Hong Award in Clinical Investigation MD Anderson Cancer Center, 2015
- Travel Award North American Neuroendocrine Tumor Society, 2014
- Join now to see all
Clinical Trials
- PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers Start of enrollment: 2016 Dec 08
- Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Start of enrollment: 2017 Feb 14
- Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors Start of enrollment: 2017 Mar 03
- Join now to see all
Publications & Presentations
PubMed
- Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide.AghaAmiri, S., Ghosh, S., Hernandez Vargas, S., Azhdarinia, A., Halperin, D.> ;Journal of Medicinal Chemistry. 2024 Feb 22
- Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy.Ross, A., Dasari, A., Cordero-Hernandez, I., Halperin, D., Yao, J., Chasen, B.> ;Endocrine-Related Cancer. 2024 Apr 1
- Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide sub...Singh, S., Ferone, D., Capdevila, J., de Herder, W., Mailman, J., Hellström, L., Liedman, H., Svedberg, A., Tiberg, F., Chan, J., Halperin, D.> ;Trials. 2024 Jan 16
- Join now to see all
Abstracts/Posters
- A prospective, multi-institutional phase II study pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumors.Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH, NANETS: North American Neuroendocrine Tumor Society Annual Meeting, Nashville, TN, USA, 10/6/2014
- Clinical Presentation and Outcomes in Patients with Advanced Pheochromcytoma/Paraganglioma: Evidence of Temozolomide EfficacyHalperin DM, Brais L, Ramaiya NH, Kulke MH, ASCO Annual Meeting, Chicago, IL, USA, 6/2014
- A phase I study of the anti-IGF-1R monoclonal antibody, IMC-A12, and everolimus in well-differentiated neuroendocrine tumorsDasari A, Phan AT, Gupta S, Hess KR, Culotta KS, Rashid A, Yeung SJ, Chen HX, Dong M, Halperin DM, Subbiah IM, Meric-Bernstam F, Yao JC, ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 1/1/2014
- Join now to see all
Press Mentions
Combination Bevacizumab plus Atezolizumab May Effectively Treat Some Neuroendocrine TumorsApril 13th, 2022- MD Anderson Research Highlights for April 13, 2022April 13th, 2022
- UTHealth Houston Researchers Awarded over $6 Million in CPRIT GrantsMarch 23rd, 2022
- Join now to see all
Committees
- Member, MD Anderson House Staff Senate 2014 - 2015
- Member, Brigham and Women's Hospital Clinicopathologic Conference Committee 2011 - 2012
- Member, Brigham and Women's Hospital Department of Medicine Educational Committee 2011 - 2012
- Member, Weill Cornell Medical College Committee on Admissions 2008 - 2009
Professional Memberships
- Member
- Associate Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
